Avanos Medical (AVNS) Stock Statistics & Valuation Metrics

Avanos Medical has a market cap or net worth of $558.63M. The enterprise value is $1.42B.

Avanos Medical has 46,243,980 shares outstanding. The number of shares has decreased by -2.65% in one year.

Avanos Medical’s return on equity (ROE) is -0.47 and return on invested capital (ROIC) is -37.63%.

The current PE Ratio of Avanos Medical is -1.87. Avanos Medical’s PEG ratio is 0.03.

In the last 12 months, Avanos Medical had revenue of 687.80M and earned -392.10M in profits. Earnings per share was -8.53.

In the last 12 months, operating cash flow was 134.40M and capital expenditures -20.40M, giving a free cash flow of 114.00M billion.

Avanos Medical pays an annual dividend of ―, resulting in a dividend yield of ―

Avanos Medical upcoming earnings date is Aug 12, 2025, TBA Not Confirmed.

Avanos Medical as a current ratio of 2.37, with Debt / Equity ratio of 21.69%

In the past 12 months, Avanos Medical has paid -17.00M in taxes.

Avanos Medical EV to EBITDA ratio is -2.30, with an EV/FCF ratio of 9.59.

Avanos Medical has $97.00M in cash and marketable securities with $140.90M in debt, giving a net cash position of $43.90M billion.

Gross margin is 54.88%, with operating margin of -57.60%, and net profit margin of -57.01%.

The average price target for Avanos Medical is $14.00, which is 11.43% higher than the current price. The consensus rating is Hold